It has been suggested that H. pylori infection may influence the efficacy of anti-PD-1/PD-L1 therapy by decreasing the expression level of miR-140 and thereby increasing the level of PD-L1 in cancer cells (55). The gene discussed is PDCD1; the disease is cancer.